Salmonella typhi Vi polysaccharide - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
VIVAXIM 1mL injection syringe composite pack
AUST R: 82745
Active ingredients:
Hepatitis a virus antigen
Salmonella typhi Vi polysaccharide

Dosage form:
Injection, suspension

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

Deletion from market:
01 Apr 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Manufacturing